Association of serum uric acid levels with the progression of Parkinson's disease in Chinese patients.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Chinese Medical Journal

• Publication date

  2012-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.3760/CMA.J.ISSN.0366-6999.2012.04.005PMID 22490478
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Variation in the Uric Acid Transporter Gene SLC2A9 and Its Association with AAO of Parkinson’s Disease

  2011cited by this paper
• Higher serum uric acid associated with decreased Parkinson's disease prevalence in a large community‐based survey

  2010cited by this paper
• Molecular mechanisms of pathogenesis of Parkinson's disease.

  2010cited by this paper
• Urate as a predictor of the rate of clinical decline in Parkinson disease.

  2009cited by this paper
• Toxic influence of chronic oral administration of paraquat on nigrostriatal dopaminergic neurons in C57BL/6 mice.

  2009cited by this paper
• Serum uric acid levels in patients with Parkinson's disease: their relationship to treatment and disease duration.

  2009cited by this paper
• Serum uric acid and clinical progression in Parkinson disease: potential biomarker for nigrostriatal failure.

  2008cited by this paper
• Diet, urate, and Parkinson's disease risk in men.

  2008cited by this paper
• Serum urate as a predictor of clinical and radiographic progression in Parkinson disease.

  2008cited by this paper
• Low plasma uric acid level in Parkinson's disease

  2007cited by this paper
• Serum uric acid levels and the risk of Parkinson disease

  2005cited by this paper
• Dietary folate deficiency and elevated homocysteine levels endanger dopaminergic neurons in models of Parkinson's disease

  2002cited by this paper
• A Reassessment of the Peroxynitrite Scavenging Activity of Uric Acid

  2002cited by this paper
• Parkinson's disease therapy: treatment of early and late disease.

  2001cited by this paper
• Accuracy of diagnosis in patients with presumed Parkinson's disease.

  1999cited by this paper
• Observations on serum uric acid levels and the risk of idiopathic Parkinson's disease.

  1996cited by this paper
• Uric acid is reduced in the substantia nigra in Parkinson's disease: effect on dopamine oxidation.

  1994cited by this paper
• L-dopa induced increases in brain uric acid in an animal model of Parkinson's disease: a relationship to behavioral activation.

  1994cited by this paper
• Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

  1992cited by this paper
• Uric acid-iron ion complexes. A new aspect of the antioxidant functions of uric acid.

  1986cited by this paper
• Effect of L-dopa on renal handling of uric acid.

  1982cited by this paper
• Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis.

  1981cited by this paper

• The role of uric acid in Parkinson’s disease: a UK brain bank pathology-validated case–control study

  2025cites this paper
• Uric Acid: A Biomarker and Pathogenic Factor of Affective Disorders and Neurodegenerative Diseases.

  2024cites this paper
• The glucocerebrosidase mutations and uric acid levels in Parkinson’s disease: A 3-years investigation of a potential biomarker”

  2022cites this paper
• Serum Uric Acid Levels in Parkinson’s Disease: A Cross-Sectional Electronic Medical Record Database Study from a Tertiary Referral Centre in Romania

  2022cites this paper
• Serum Uric Acid in LRRK2 Related Parkinson’s Disease: Longitudinal Data from the PPMI Study

  2021cites this paper
• A Study of the Relationship Between Uric Acid and Substantia Nigra Brain Connectivity in Patients With REM Sleep Behavior Disorder and Parkinson's Disease

  2020cites this paper
• Creatinine and C-reactive protein in amyotrophic lateral sclerosis, multiple sclerosis and Parkinson’s disease

  2020cites this paper
• The Relationship Between Serum Uric Acid Levels and Clinical Features in Essential Tremor.

  2020cites this paper
• Serum Uric Acid, Serum Uric Acid to Serum Creatinine Ratio and Serum Bilirubin in Patients With Parkinson’s Disease: A Case-Control Study

  2020influential citation
• Nutraceuticals Targeting Generation and Oxidant Activity of Peroxynitrite May Aid Prevention and Control of Parkinson’s Disease

  2020cites this paper
• Does Serum Urate Change as Parkinson’s Disease Progresses?

  2020cites this paper
• Estimation of serum uric acid levels in Parkinson’s disease patients along with their comorbidities and treatment pattern

  2019cites this paper
• Glassy carbon electrode modified with G-MoS2-Nafion acts as an electrochemical biosensor to determine uric acid in human serum

  2018cites this paper
• Clinical correlates and advanced processing of the dopamine transporter spect - applications in parkinsonism.

  2017cites this paper
• Serum uric acid levels in patients with Parkinson’s disease: A meta-analysis

  2017cites this paper
• Targeting urate to reduce oxidative stress in Parkinson disease.

  2017cites this paper
• Lower levels of uric acid and striatal dopamine in non-tremor dominant Parkinson's disease subtype

  2017cites this paper
• Elevated Cystatin C Levels Are Associated with Cognitive Impairment and Progression of Parkinson Disease

  2016influential citation
• Purines: forgotten mediators in traumatic brain injury

  2016cites this paper
• Dietary and Genetic Risk Factors for Parkinson's Disease

  2016cites this paper
• Serum uric acid levels in Parkinson's disease and related disorders

  2016cites this paper
• The relation of serum uric acid levels with l-Dopa treatment and progression in patients with Parkinson’s disease

  2016influential citation
• Uric Acid: A Biomarker to Predict Clinical Progression of Parkinson Disease

  2015influential citation
• Dopamine Agonists Exert Nurr1-inducing Effect in Peripheral Blood Mononuclear Cells of Patients with Parkinson's Disease

  2015cites this paper
• Review of concepts and controversies of uric acid as antioxidant and pro- oxidant – an uncertainty

  2015cites this paper
• Review of Concepts and Controversies of Uric Acid as Antioxidant and Pro-Oxidant Ürik Asidin Antioksidan ve Pro-Oksidan Özellikleri ile İlgili Kavram ve Tartişmalarinin Derlemesi

  2015cites this paper
• Research on experimental models of neurodegenerative disorders and radiation-induced brain injury

  2014cites this paper
• Research on experimental models of neurodegenerative disorders and radiation-induced brain injury

  2014cites this paper
• For peer review only Low uric acid levels in patients with Parkinson's disease

  2013cites this paper
• Low uric acid levels in patients with Parkinson's disease: evidence from meta-analysis

  2013cites this paper
• Serum uric acid levels correlate with recurrence of paroxysmal atrial fibrillation after catheter ablation.

  2013cites this paper
• Biomarkers of Parkinson's disease: current status and future perspectives.

  2013cites this paper
• Assessment of the role of multidrug resistance-associated proteins in MPTP neurotoxicity in mice.

  2013cites this paper
• Serum Urate and the Risk of Parkinson's Disease: Results From a Meta-Analysis

  2013cites this paper
• Award Number: W81XWH-11-1-0150 TITLE: Protection by Purines in Toxin Models of Parkinson's Disease PRINCIPAL INVESTIGATOR:

  2012cites this paper
• Urate in Parkinson’s Disease: More Than a Biomarker?

  2012cites this paper
• Analysis of Clinical Characteristics in 107 Patients with Subacute Combined Degeneration of

  year unknowncites this paper